February 25, 2008
Prospector
Profile
2-25-003
 
Avitar, Inc. NAICS 339113
65 Dan Road Canton, MA 02021 Description Surgical Supplies Mfg.
(781) 821-2440 Employees 36
http://www.avitarinc.com/ Revenue (mil) 3.1100
  Income (mil) -2.2600
  Assets (mil) 1.7500
  Liability (mil) 8.3800
  (for the year ended 2007-09-30)
 
Category: Loss/Deficit
 
Event: Avitar, Inc., reported a net loss of $1,329,617 for the first quarter ended December 31, 2007, compared with a net loss of $943,388 in the same period ended December 31, 2006. Sales for the three months ended December 31, 2007, decreased $443,428 or approximately 47.0%, to $505,386 from $948,814 for the corresponding period of the prior year. The Company's consolidated balance sheet at December 31, 2007, showed $1,452,056 in total assets, $9,335,504 in total liabilities, and $3,215,490 in convertible preferred stock and redeemable convertible preferred stock, resulting in an $11,098,938 total stockholders' deficit. At December 31, 2007, the company's consolidated balance sheet also showed strained liquidity with $454,756 in total current assets available to pay $5,248,361 in total current liabilities.
 
Intellectual Property: The Company currently relies on a combination of patents, trade secrets, trademark law and non-disclosure agreements to establish and protect its proprietary rights in its products. The Company currently holds numerous United States patents, has applications pending for additional patents and has licenses to use certain patents. In addition, the Company has certain registered and other trademarks. [SEC Filing 10-KSB 12-28-07]
 
Description: Avitar, Inc., through its wholly owned subsidiary Avitar Technologies, Inc., develops, manufactures, markets and sells diagnostic point of contact tests and customized proprietary hydrophilic polyurethane foam applications for medical, diagnostics, dental and consumer use.
 
Officers: Peter P. Phildius (Chair & CEO); Douglas W. Scott (Pres. & COO); Jay C. Leatherman, Jr. (VP, CFO & Sec.); Peter Cholakis (VP-Mktg.); Neil R. Gordon (Dir.); Charles R. McCarthy (Dir.)
 
Auditor: BDO Seidman LLP
 
Securities: Common Stock Symbol AVTI.OB; OTC BB; 134,188,868 common shares outstanding as of February 8, 2008.
 
 
 
return to main page